BRIEF published on 05/15/2024 at 12:43, 1 year 8 months ago 4finance Holding S.A. Announces First Quarter 2024 Results with Strong Performance Net Profit Growth Digital Lending 4finance Credit Rating Quarterly Financial Results
BRIEF published on 05/15/2024 at 12:43, 1 year 8 months ago 4finance Holding SA annonce des résultats du premier trimestre 2024 avec de solides performances 4finance Cote De Crédit Résultats Financiers Trimestriels Prêt Numérique Croissance Du Bénéfice Net
BRIEF published on 05/15/2024 at 12:35, 1 year 8 months ago Zomedica Introduces Over-the-Air Update Capabilities for TRUFORMA Platform Zomedica Veterinary Health TRUFORMA Diagnostic Platforms OTA Updates
BRIEF published on 05/15/2024 at 12:35, 1 year 8 months ago Zomedica présente des capacités de mise à jour en direct pour la plateforme TRUFORMA Zomedica Santé Vétérinaire TRUFORMA Plateformes De Diagnostic Mises À Jour OTA
BRIEF published on 05/15/2024 at 12:35, 1 year 8 months ago Kentucky Peerless to Launch Second Batch of Rum Barrel Finished Bourbon Bourbon Rum Barrel Finish Kentucky Peerless Craft Spirits Distillery
BRIEF published on 05/15/2024 at 12:35, 1 year 8 months ago Kentucky Peerless va lancer un deuxième lot de bourbon fini en fût de rhum Bourbon Finition Du Fût De Rhum Kentucky Sans Égal Spiritueux Artisanaux Distillerie
BRIEF published on 05/15/2024 at 12:35, 1 year 8 months ago GEE Group to Discuss Fiscal 2024 Q2 Earnings in Upcoming Investor Webcast Financial Results Investor Webcast GEE Group Q2 Earnings 2024 Fiscal Second Quarter
BRIEF published on 05/15/2024 at 12:35, 1 year 8 months ago Le groupe GEE discutera des résultats du deuxième trimestre de l'exercice 2024 lors de la prochaine webémission destinée aux investisseurs Résultats Financiers Webdiffusion Pour Les Investisseurs Résultats Du Deuxième Trimestre Groupe GEE Deuxième Trimestre Fiscal 2024
BRIEF published on 05/15/2024 at 12:35, 1 year 8 months ago NanoViricides Reports Financial Update and Advancements in Clinical Trials NanoViricides NV-387 Financial Report Clinical Trials Antiviral Treatment
BRIEF published on 05/15/2024 at 12:35, 1 year 8 months ago NanoViricides annonce une mise à jour financière et des progrès dans les essais cliniques NanoViricides NV-387 Rapport Financier Essais Cliniques Traitement Antiviral
Published on 01/20/2026 at 15:45, 2 hours 13 minutes ago Caldwell Announces New Sponsorship on Canada's Outstanding CEO of the Year(R)
Published on 01/20/2026 at 15:00, 2 hours 58 minutes ago Pivotree Partners with OroCommerce to Deliver Unmatched B2B eCommerce Powered by Mastered Data
Published on 01/20/2026 at 14:30, 3 hours 28 minutes ago Karbon-X Secures up to $25 Million in Strategic Financing to Accelerate Growth and Expand Global Climate Solutions Platform
Published on 01/20/2026 at 14:30, 3 hours 28 minutes ago Core Silver Confirms Expansion of Laverdiere Porphyry by 280 Metres Through Drilling
Published on 01/20/2026 at 14:30, 3 hours 28 minutes ago Innodata Awarded Prime Contract Position on U.S. Missile Defense Agency's IDIQ SHIELD Program
Published on 01/20/2026 at 16:15, 1 hour 43 minutes ago Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy
Published on 01/20/2026 at 16:00, 1 hour 58 minutes ago Orion Innovation Recognized in Connected Product Engineering Services, Q4 2025 Analyst Evaluation
Published on 01/20/2026 at 15:30, 2 hours 27 minutes ago swissnet Group Secures Major Hospitality Technology Project in Abu Dhabi
Published on 01/20/2026 at 17:45, 13 minutes ago Evolution au sein de la direction générale de Baikowski®
Published on 01/20/2026 at 07:30, 10 hours 28 minutes ago Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling
Published on 01/20/2026 at 07:30, 10 hours 28 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
Published on 01/20/2026 at 07:30, 10 hours 28 minutes ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy
